Report Detail

Pharma & Healthcare Global Tumor Necrosis Factor Alpha Inhibitors Market Professional Survey Report 2019

  • RnM3744010
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Executive Summary

      1 Industry Overview of Tumor Necrosis Factor Alpha Inhibitors

      • 1.1 Definition of Tumor Necrosis Factor Alpha Inhibitors
      • 1.2 Tumor Necrosis Factor Alpha Inhibitors Segment by Type
        • 1.2.1 Global Tumor Necrosis Factor Alpha Inhibitors Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Humira
        • 1.2.3 Enbrel
        • 1.2.4 Remicade
        • 1.2.5 Others
      • 1.3 Tumor Necrosis Factor Alpha Inhibitors Segment by Applications
        • 1.3.1 Global Tumor Necrosis Factor Alpha Inhibitors Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Medicine
        • 1.3.3 Scientific Research
        • 1.3.4 Others
      • 1.4 Global Tumor Necrosis Factor Alpha Inhibitors Overall Market
        • 1.4.1 Global Tumor Necrosis Factor Alpha Inhibitors Revenue (2014-2025)
        • 1.4.2 Global Tumor Necrosis Factor Alpha Inhibitors Production (2014-2025)
        • 1.4.3 North America Tumor Necrosis Factor Alpha Inhibitors Status and Prospect (2014-2025)
        • 1.4.4 Europe Tumor Necrosis Factor Alpha Inhibitors Status and Prospect (2014-2025)
        • 1.4.5 China Tumor Necrosis Factor Alpha Inhibitors Status and Prospect (2014-2025)
        • 1.4.6 Japan Tumor Necrosis Factor Alpha Inhibitors Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Tumor Necrosis Factor Alpha Inhibitors Status and Prospect (2014-2025)
        • 1.4.8 India Tumor Necrosis Factor Alpha Inhibitors Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Tumor Necrosis Factor Alpha Inhibitors
      • 2.3 Manufacturing Process Analysis of Tumor Necrosis Factor Alpha Inhibitors
      • 2.4 Industry Chain Structure of Tumor Necrosis Factor Alpha Inhibitors

      3 Development and Manufacturing Plants Analysis of Tumor Necrosis Factor Alpha Inhibitors

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Tumor Necrosis Factor Alpha Inhibitors Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Tumor Necrosis Factor Alpha Inhibitors
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Tumor Necrosis Factor Alpha Inhibitors Production and Capacity Analysis
      • 4.2 Tumor Necrosis Factor Alpha Inhibitors Revenue Analysis
      • 4.3 Tumor Necrosis Factor Alpha Inhibitors Price Analysis
      • 4.4 Market Concentration Degree

      5 Tumor Necrosis Factor Alpha Inhibitors Regional Market Analysis

      • 5.1 Tumor Necrosis Factor Alpha Inhibitors Production by Regions
        • 5.1.1 Global Tumor Necrosis Factor Alpha Inhibitors Production by Regions
        • 5.1.2 Global Tumor Necrosis Factor Alpha Inhibitors Revenue by Regions
      • 5.2 Tumor Necrosis Factor Alpha Inhibitors Consumption by Regions
      • 5.3 North America Tumor Necrosis Factor Alpha Inhibitors Market Analysis
        • 5.3.1 North America Tumor Necrosis Factor Alpha Inhibitors Production
        • 5.3.2 North America Tumor Necrosis Factor Alpha Inhibitors Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Tumor Necrosis Factor Alpha Inhibitors Import and Export
      • 5.4 Europe Tumor Necrosis Factor Alpha Inhibitors Market Analysis
        • 5.4.1 Europe Tumor Necrosis Factor Alpha Inhibitors Production
        • 5.4.2 Europe Tumor Necrosis Factor Alpha Inhibitors Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Tumor Necrosis Factor Alpha Inhibitors Import and Export
      • 5.5 China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
        • 5.5.1 China Tumor Necrosis Factor Alpha Inhibitors Production
        • 5.5.2 China Tumor Necrosis Factor Alpha Inhibitors Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Tumor Necrosis Factor Alpha Inhibitors Import and Export
      • 5.6 Japan Tumor Necrosis Factor Alpha Inhibitors Market Analysis
        • 5.6.1 Japan Tumor Necrosis Factor Alpha Inhibitors Production
        • 5.6.2 Japan Tumor Necrosis Factor Alpha Inhibitors Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Tumor Necrosis Factor Alpha Inhibitors Import and Export
      • 5.7 Southeast Asia Tumor Necrosis Factor Alpha Inhibitors Market Analysis
        • 5.7.1 Southeast Asia Tumor Necrosis Factor Alpha Inhibitors Production
        • 5.7.2 Southeast Asia Tumor Necrosis Factor Alpha Inhibitors Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Tumor Necrosis Factor Alpha Inhibitors Import and Export
      • 5.8 India Tumor Necrosis Factor Alpha Inhibitors Market Analysis
        • 5.8.1 India Tumor Necrosis Factor Alpha Inhibitors Production
        • 5.8.2 India Tumor Necrosis Factor Alpha Inhibitors Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Tumor Necrosis Factor Alpha Inhibitors Import and Export

      6 Tumor Necrosis Factor Alpha Inhibitors Segment Market Analysis (by Type)

      • 6.1 Global Tumor Necrosis Factor Alpha Inhibitors Production by Type
      • 6.2 Global Tumor Necrosis Factor Alpha Inhibitors Revenue by Type
      • 6.3 Tumor Necrosis Factor Alpha Inhibitors Price by Type

      7 Tumor Necrosis Factor Alpha Inhibitors Segment Market Analysis (by Application)

      • 7.1 Global Tumor Necrosis Factor Alpha Inhibitors Consumption by Application
      • 7.2 Global Tumor Necrosis Factor Alpha Inhibitors Consumption Market Share by Application (2014-2019)

      8 Tumor Necrosis Factor Alpha Inhibitors Major Manufacturers Analysis

      • 8.1 GlaxoSmithKline
        • 8.1.1 GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.1.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.1.3 GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sanofi
        • 8.2.1 Sanofi Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.2.2 Sanofi Product Introduction, Application and Specification
        • 8.2.3 Sanofi Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Novartis
        • 8.3.1 Novartis Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.3.2 Novartis Product Introduction, Application and Specification
        • 8.3.3 Novartis Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 AstraZeneca
        • 8.4.1 AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.4.2 AstraZeneca Product Introduction, Application and Specification
        • 8.4.3 AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 AbbVie
        • 8.5.1 AbbVie Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.5.2 AbbVie Product Introduction, Application and Specification
        • 8.5.3 AbbVie Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 LG Life Sciences
        • 8.6.1 LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.6.2 LG Life Sciences Product Introduction, Application and Specification
        • 8.6.3 LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Janssen Biotech
        • 8.7.1 Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.7.2 Janssen Biotech Product Introduction, Application and Specification
        • 8.7.3 Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 AryoGen Pharmed
        • 8.8.1 AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.8.2 AryoGen Pharmed Product Introduction, Application and Specification
        • 8.8.3 AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Momenta Pharmaceuticals
        • 8.9.1 Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.9.2 Momenta Pharmaceuticals Product Introduction, Application and Specification
        • 8.9.3 Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 HanAll Biopharma
        • 8.10.1 HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Production Sites and Area Served
        • 8.10.2 HanAll Biopharma Product Introduction, Application and Specification
        • 8.10.3 HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Zydus Cadila

      9 Development Trend of Analysis of Tumor Necrosis Factor Alpha Inhibitors Market

      • 9.1 Global Tumor Necrosis Factor Alpha Inhibitors Market Trend Analysis
        • 9.1.1 Global Tumor Necrosis Factor Alpha Inhibitors Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Tumor Necrosis Factor Alpha Inhibitors Regional Market Trend
        • 9.2.1 North America Tumor Necrosis Factor Alpha Inhibitors Forecast 2019-2025
        • 9.2.2 Europe Tumor Necrosis Factor Alpha Inhibitors Forecast 2019-2025
        • 9.2.3 China Tumor Necrosis Factor Alpha Inhibitors Forecast 2019-2025
        • 9.2.4 Japan Tumor Necrosis Factor Alpha Inhibitors Forecast 2019-2025
        • 9.2.5 Southeast Asia Tumor Necrosis Factor Alpha Inhibitors Forecast 2019-2025
        • 9.2.6 India Tumor Necrosis Factor Alpha Inhibitors Forecast 2019-2025
      • 9.3 Tumor Necrosis Factor Alpha Inhibitors Market Trend (Product Type)
      • 9.4 Tumor Necrosis Factor Alpha Inhibitors Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Tumor Necrosis Factor Alpha Inhibitors Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and seronegative spondyloarthropathies, can be treated with the help of these drugs.

        The global Tumor Necrosis Factor Alpha Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Tumor Necrosis Factor Alpha Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tumor Necrosis Factor Alpha Inhibitors market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Tumor Necrosis Factor Alpha Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Tumor Necrosis Factor Alpha Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        GlaxoSmithKline
        Sanofi
        Novartis
        AstraZeneca
        AbbVie
        LG Life Sciences
        Janssen Biotech
        AryoGen Pharmed
        Momenta Pharmaceuticals
        HanAll Biopharma
        Zydus Cadila

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Humira
        Enbrel
        Remicade
        Others

        Segment by Application
        Medicine
        Scientific Research
        Others


        Summary:
        Get latest Market Research Reports on Tumor Necrosis Factor Alpha Inhibitors. Industry analysis & Market Report on Tumor Necrosis Factor Alpha Inhibitors is a syndicated market report, published as Global Tumor Necrosis Factor Alpha Inhibitors Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Tumor Necrosis Factor Alpha Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,709.64
        4,064.46
        5,419.27
        3,161.28
        4,741.93
        6,322.57
        379,778.00
        569,667.00
        759,556.00
        251,317.85
        376,976.77
        502,635.70
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report